EOLS – Evolus, Inc.
Float Short %
22.89
Margin Of Safety %
Put/Call OI Ratio
1.25
EPS Next Q Diff
0.37
EPS Last/This Y
0.26
EPS This/Next Y
0.69
Price
7.2
Target Price
18.83
Analyst Recom
1.29
Performance Q
-29.37
Relative Volume
0.53
Beta
1.09
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | EOLS | 6.72 | 1.13 | 1.06 | 20824 |
| 2025-08-18 | EOLS | 6.7 | 1.23 | 0.00 | 19047 |
| 2025-08-19 | EOLS | 7.14 | 1.23 | 0.07 | 19048 |
| 2025-08-20 | EOLS | 7.24 | 1.24 | 0.32 | 19029 |
| 2025-08-21 | EOLS | 7.43 | 1.23 | 0.14 | 19045 |
| 2025-08-22 | EOLS | 7.68 | 1.24 | 0.08 | 19028 |
| 2025-08-25 | EOLS | 7.41 | 1.25 | 0.11 | 18973 |
| 2025-08-26 | EOLS | 7.66 | 1.25 | 0.12 | 18940 |
| 2025-08-27 | EOLS | 7.57 | 1.25 | 0.14 | 18963 |
| 2025-08-28 | EOLS | 7.51 | 1.25 | 1.25 | 18992 |
| 2025-08-29 | EOLS | 7.64 | 1.25 | 0.00 | 19021 |
| 2025-09-02 | EOLS | 7.51 | 1.26 | 0.36 | 18951 |
| 2025-09-03 | EOLS | 7.39 | 1.26 | 0.71 | 18945 |
| 2025-09-04 | EOLS | 7.53 | 1.26 | 0.32 | 18945 |
| 2025-09-05 | EOLS | 7.68 | 1.27 | 0.00 | 18935 |
| 2025-09-08 | EOLS | 7.62 | 1.27 | 0.37 | 18939 |
| 2025-09-09 | EOLS | 7.41 | 1.25 | 0.50 | 19071 |
| 2025-09-10 | EOLS | 7.35 | 1.25 | 0.01 | 19075 |
| 2025-09-11 | EOLS | 7.51 | 1.25 | 0.04 | 19040 |
| 2025-09-12 | EOLS | 7.2 | 1.25 | 0.01 | 19089 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | EOLS | 6.72 | 12.3 | 11.2 | -0.55 |
| 2025-08-18 | EOLS | 6.70 | 12.3 | 12.5 | -0.55 |
| 2025-08-19 | EOLS | 7.13 | 12.3 | 10.9 | -0.55 |
| 2025-08-20 | EOLS | 7.24 | 12.3 | 12.0 | -0.55 |
| 2025-08-21 | EOLS | 7.43 | 12.3 | 11.7 | -0.55 |
| 2025-08-22 | EOLS | 7.69 | 12.3 | 11.5 | -0.55 |
| 2025-08-25 | EOLS | 7.41 | 12.3 | 13.2 | -0.55 |
| 2025-08-26 | EOLS | 7.65 | 12.3 | 11.7 | -0.55 |
| 2025-08-27 | EOLS | 7.58 | 12.3 | 12.6 | -0.55 |
| 2025-08-28 | EOLS | 7.51 | 12.3 | 12.6 | -0.55 |
| 2025-08-29 | EOLS | 7.63 | 12.3 | 12.0 | -0.55 |
| 2025-09-02 | EOLS | 7.51 | 12.3 | 12.7 | -0.55 |
| 2025-09-03 | EOLS | 7.38 | 12.3 | 62.0 | -0.55 |
| 2025-09-04 | EOLS | 7.53 | 12.3 | 62.7 | -0.55 |
| 2025-09-05 | EOLS | 7.66 | 12.3 | 62.7 | -0.55 |
| 2025-09-08 | EOLS | 7.61 | 12.3 | 62.2 | -0.55 |
| 2025-09-09 | EOLS | 7.41 | 12.3 | 61.8 | -0.55 |
| 2025-09-10 | EOLS | 7.34 | 12.3 | 62.2 | -0.55 |
| 2025-09-11 | EOLS | 7.51 | 12.3 | 62.7 | -0.55 |
| 2025-09-12 | EOLS | 7.20 | 12.3 | 61.6 | -0.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | EOLS | -3.83 | 4.41 | 23.56 |
| 2025-08-18 | EOLS | -3.46 | 3.43 | 24.63 |
| 2025-08-19 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-20 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-21 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-22 | EOLS | -2.62 | 3.43 | 24.63 |
| 2025-08-25 | EOLS | -2.62 | 8.60 | 26.68 |
| 2025-08-26 | EOLS | -1.85 | 8.60 | 26.68 |
| 2025-08-27 | EOLS | -1.89 | 8.60 | 21.15 |
| 2025-08-28 | EOLS | -1.89 | 8.60 | 21.15 |
| 2025-08-29 | EOLS | -1.89 | 8.60 | 21.15 |
| 2025-09-02 | EOLS | -1.89 | 8.06 | 21.02 |
| 2025-09-03 | EOLS | -1.93 | 8.06 | 21.02 |
| 2025-09-04 | EOLS | -1.93 | 8.06 | 21.02 |
| 2025-09-05 | EOLS | -1.93 | 8.06 | 21.02 |
| 2025-09-08 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-09 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-10 | EOLS | -1.93 | 9.35 | 21.02 |
| 2025-09-11 | EOLS | -1.93 | 9.35 | 22.89 |
| 2025-09-12 | EOLS | -1.93 | 9.35 | 22.89 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.3
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
0.07
Insider Transactions
-1.93
Institutional Transactions
9.35
Beta
1.09
Average Sales Estimate Current Quarter
67
Average Sales Estimate Next Quarter
91
Fair Value
Quality Score
31
Growth Score
52
Sentiment Score
35
Actual DrawDown %
59.6
Max Drawdown 5-Year %
-68.4
Target Price
18.83
P/E
Forward P/E
25.28
PEG
P/S
1.67
P/B
P/Free Cash Flow
EPS
-0.97
Average EPS Est. Cur. Y
-0.55
EPS Next Y. (Est.)
0.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-22.31
Relative Volume
0.53
Return on Equity vs Sector %
307.5
Return on Equity vs Industry %
324.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.42
EBIT Estimation
61.6
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 394
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading